CSIMarket
 


Kinnate Biopharma Inc   (KNTE)
Other Ticker:  
 


Kinnate Biopharma Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Kinnate Biopharma Inc 's ROA in the third quarter of 2023?
Kinnate Biopharma Inc recorded a cumulative net loss of $-127 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -55.12%.

However, within the Healthcare sector 681 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 4144, from total ROA ranking in the second quarter of 2023 at 4300.

What is ROA?


Return On Assets (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -36.84 % -32.9 % -30.28 % -24.75 % -22.32 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -127 -127 -122 -116 -39
Return On Assets (TTM) -55.12 % -49.22 % -42.95 % -37.39 % -11.56 %
KNTE's Total Ranking # 4144 # 4300 # 4333 # 4808 # 3782
Total Assets (TTM) in million 190 216 241 276 300
Seq. Total Assets Change -12.19 % -10.57 % -12.56 % -8.01 % -6.71 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 299
Sector # 682
Overall # 4128

Return On Assets Statistics
High Average Low
-7.14 %
-30.15 %
-54.72 %
  (Sep 30 2023)





Financial Statements
Kinnate Biopharma Inc 's Assets $ 190 million KNTE's Balance sheet
Kinnate Biopharma Inc 's Income $ -31 million Quarterly KNTE's Income Statement
KNTE's Income by Division See KNTE's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021

FY

FY

FY
Y / Y Total Assets Change -24.75 % - - - -
Total Assets in million 276 367 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -116 -90 0 0 0
Return On Assets -42.12 % -24.47 % - - -




More Return On Assets Ratios
KNTE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KNTE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for KNTE's Competitors
Roa for Kinnate Biopharma Inc 's Suppliers
Return On Assets for KNTE's Customers

You may also want to know
KNTE's Roi KNTE's Inventory Turnover Ratio KNTE's Growth Rates KNTE's Dividend Comparisons
KNTE's Profitability Ratios KNTE's Asset Turnover Ratio KNTE's Dividend Growth
KNTE's Roe KNTE's Valuation Ratios KNTE's Financial Strength Ratios KNTE's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA


Date modified: 2023-11-12T10:02:19+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com